Sector consensus Becton, Dickinson and Company

Equities

Real-time Estimate Cboe BZX Other stock markets 08:01:06 17/04/2026 pm IST			5-day change	1st Jan Change
158.80 ^USD	+2.57%		+2.85%	-18.27%

14/04	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT
10/04	Becton, Dickinson and Company Announces Retirement of Richard Byrd from BD, Effective June 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
BECTON, DICKINSON AND COMPANY	192.31	+24.21%	13
ABBOTT LABORATORIES	128.36	+34.45%	25
MEDTRONIC PLC	109.08	+27.36%	25
HOYA CORPORATION	29,253.33	-2.49%	15
CENCORA, INC.	402.92	+24.99%	12
MEDLINE INC.	53.52	+14.01%	27
DEXCOM, INC.	86.88	+41.88%	24
STERIS PLC	279.29	+26.97%	7
SARTORIUS STEDIM BIOTECH	233.21	+28%	14
TERUMO CORPORATION	2,871.54	+31.24%	13
WEST PHARMACEUTICAL SERVICES, INC.	317.46	+17.66%	13
ZIMMER BIOMET HOLDINGS, INC.	102.95	+8.62%	21
INSULET CORPORATION	333.3	+65.44%	23
ALIGN TECHNOLOGY, INC.	204.43	+10.49%	14
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	40.85	+5.92%	12
GLOBUS MEDICAL, INC.	110.08	+18.68%	12
SOLVENTUM CORPORATION	85.17	+23.64%	12
BAXTER INTERNATIONAL INC.	22.12	+21.91%	13
BIO-RAD LABORATORIES, INC.	302.5	+3.92%	4
REPLIGEN CORPORATION	182.12	+43.3%	17
Average	1,765.57	+23.51%	16
Weighted average by Cap.	2,883.44	+24.69%	19